Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer

Surgery (United States)

Volumn 154, Issue 5, 2013, Pages 1078-1086

  Sugiura, Teiichi ^a   Uesaka, Katsuhiko ^a   Mihara, Kisho ^a   Sasaki, Keiko ^a   Kanemoto, Hideyuki ^a   Mizuno, Takashi ^a   Okamura, Yukiyasu ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DIFFERENTIATION; FEMALE; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; CARCINOMA, PANCREATIC DUCTAL; JAPAN; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PATHOLOGY; PROGNOSIS; STATISTICS AND NUMERICAL DATA;

AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS;

EID: 84886091225     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.04.015     Document Type: Article

References (47)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. N. Alexakis, C. Halloran, M. Raraty, P. Ghaneh, R. Sutton, and J.P. Neoptolemos Current standards of surgery for pancreatic cancer Br J Surg 91 2004 1410 1427
3. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903
4. J.P. Neoptolemos, D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, and H. Hickey A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
5. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. van Pel, M.L. Couvreur, and C.H. Veenhof Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776 782 discussion 82-4
6. R. Gutt, S.L. Liauw, and R.R. Weichselbaum Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol 6 2009 38 46
7. M.J. Moore, D. Goldstein, J. Hamm, A. Figer, J.R. Hecht, and S. Gallinger Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 2007 1960 1966
8. H.Q. Xiong, A. Rosenberg, A. LoBuglio, W. Schmidt, R.A. Wolff, and J. Deutsch Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial J Clin Oncol 22 2004 2610 2616
9. H.L. Kindler, G. Friberg, D.A. Singh, G. Locker, S. Nattam, and M. Kozloff Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 23 2005 8033 8040
10. A. Marten, and M.W. Buchler Immunotherapy of pancreatic carcinoma Curr Opin Investig Drugs 9 2008 565 569
11. C.J. Yeo, J.L. Cameron, K.D. Lillemoe, J.V. Sitzmann, R.H. Hruban, and S.N. Goodman Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 1995 721 731 discussion 31-3
12. C. Sperti, C. Pasquali, A. Piccoli, and S. Pedrazzoli Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg 83 1996 625 631
13. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, and R.A. Abrams Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
14. J.M. Winter, J.L. Cameron, K.A. Campbell, M.A. Arnold, D.C. Chang, and J. Coleman 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience J Gastrointest Surg 10 2006 1199 1210 discussion 210-1
15. C. Bassi, D.D. Stocken, A. Olah, H. Friess, J. Buckels, and H. Hickey Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial Dig Surg 22 2005 353 363
16. G. Butturini, D.D. Stocken, M.N. Wente, H. Jeekel, J.H. Klinkenbijl, and K.E. Bakkevold Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 2008 75 83 discussion 83
17. O. Ishikawa, H. Ohhigashi, Y. Sasaki, T. Kabuto, I. Fukuda, and H. Furukawa Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head Ann Surg 208 1988 215 220
18. T. Nagakawa, M. Nagamori, F. Futakami, Y. Tsukioka, M. Kayahara, and T. Ohta Results of extensive surgery for pancreatic carcinoma Cancer 77 1996 640 645
19. A. Nakao, S. Takeda, S. Inoue, S. Nomoto, N. Kanazumi, and H. Sugimoto Indications and techniques of extended resection for pancreatic cancer World J Surg 30 2006 976 982 discussion 83-4
20. J. Hernandez, J. Mullinax, W. Clark, P. Toomey, D. Villadolid, and C. Morton Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins Ann Surg 250 2009 76 80
21. J.P. Neoptolemos, D.D. Stocken, J.A. Dunn, J. Almond, H.G. Beger, and P. Pederzoli Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 234 2001 758 768
22. J. Luttges, I. Vogel, M. Menke, D. Henne-Bruns, B. Kremer, and G. Kloppel The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas Virchows Arch 433 1998 237 242
23. C.S. Verbeke, D. Leitch, K.V. Menon, M.J. McMahon, P.J. Guillou, and A. Anthoney Redefining the R1 resection in pancreatic cancer Br J Surg 93 2006 1232 1237
24. T.J. Howard, J.E. Krug, J. Yu, N.J. Zyromski, C.M. Schmidt, and L.E. Jacobson A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer J Gastrointest Surg 10 2006 1338 1345 discussion 45-6
25. C.P. Raut, J.F. Tseng, C.C. Sun, H. Wang, R.A. Wolff, and C.H. Crane Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
26. T.M. Breslin, K.R. Hess, D.B. Harbison, M.E. Jean, K.R. Cleary, and A.P. Dackiw Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol 8 2001 123 132
27. S.P. Cleary, R. Gryfe, M. Guindi, P. Greig, L. Smith, and R. Mackenzie Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors J Am Coll Surg 198 2004 722 731
28. J. Fatima, T. Schnelldorfer, J. Barton, C.M. Wood, H.J. Wiste, and T.C. Smyrk Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival Arch Surg 145 2010 167 172
29. L.H. Sobin, M.K. Gospodarowicz, and C. Witterkind TNM Classification of malignant tumors 7th ed. 2009 Wiley-Blackwell New York
30. F. Campbell, M. Bennett, and A.J. Foukis Minimum dataset for histopathological reporting of pancreatic, ampulla of vater and bile duct carcinoma 2002 Royal College of Pathologists London
31. H. Furukawa, K. Uesaka, and N. Boku Treatment decision making in pancreatic adenocarcinoma: multidisciplinary team discussion with multidetector-row computed tomography Arch Surg 143 2008 275 280 discussion 81
32. S. Hirano, S. Kondo, T. Hara, Y. Ambo, E. Tanaka, and T. Shichinohe Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results Ann Surg 246 2007 46 51
33. T. Kinoshita, K. Uesaka, Y. Shimizu, H. Sakamoto, W. Kimura, and S. Sunada Effects of adjuvant intraoperative radiation therapy after curative resection in pancreatic cancer patients: results of a randomized study by 11 institutions in Japan J Clin Oncol 27 2009 15s (suppl; abstr 4622)
34. J.P. Society General rules for the study of pancreatic cancer 2 ed. 2003 Kanehara Tokyo
35. H. Oettle, S. Post, P. Neuhaus, K. Gellert, J. Langrehr, and K. Ridwelski Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 2007 267 277
36. H. Riediger, T. Keck, U. Wellner, A. zur Hausen, U. Adam, and U.T. Hopt The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer J Gastrointest Surg 13 2009 1337 1344
37. S. Nagai, T. Fujii, Y. Kodera, M. Kanda, T.T. Sahin, and A. Kanzaki Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas Pancreas 40 2011 3 9
38. K. Shimada, T. Sano, Y. Sakamoto, and T. Kosuge Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma Ann Surg Oncol 13 2006 1569 1578
39. M. Kanda, T. Fujii, T.T. Sahin, A. Kanzaki, S. Nagai, and S. Yamada Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas Ann Surg 251 2010 483 487
40. N.B. Jamieson, A.K. Foulis, K.A. Oien, J.J. Going, P. Glen, and E.J. Dickson Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma Ann Surg 251 2010 1003 1010
41. I. Esposito, J. Kleeff, F. Bergmann, C. Reiser, E. Herpel, and H. Friess Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 2008 1651 1660
42. F. Campbell, R.A. Smith, P. Whelan, R. Sutton, M. Raraty, and J.P. Neoptolemos Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin Histopathology 55 2009 277 283
43. M. Kayahara, T. Nagakawa, K. Ueno, T. Ohta, T. Takeda, and I. Miyazaki An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 1993 2118 2123
44. J. Westerdahl, A. Andren-Sandberg, and I. Ihse Recurrence of exocrine pancreatic cancer-local or hepatic? Hepatogastroenterology 40 1993 384 387
45. C. Sperti, C. Pasquali, A. Piccoli, and S. Pedrazzoli Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 1997 195 200
46. S. Hishinuma, Y. Ogata, M. Tomikawa, I. Ozawa, K. Hirabayashi, and S. Igarashi Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings J Gastrointest Surg 10 2006 511 518
47. S. Takahashi, T. Kinoshita, M. Konishi, N. Gotohda, Y. Kato, and T. Kobayashi Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment J Hepatobiliary Pancreat Sci 18 2011 567 574